Literature DB >> 30878334

Pancreatic cancer: Best supportive care.

Anne-Laure Védie1, Cindy Neuzillet2.   

Abstract

Palliative and supportive care holds a major place in pancreatic ductal adenocarcinoma (PDAC) management. It aims to prevent and reduce symptoms and hospital admissions, while ensuring optimal health-related quality of life (HRQoL), which has been reported to be correlated with overall survival in PDAC. Best supportive care includes non-specific treatment of pain, anxiety and depression, chemotherapy-related toxicities, as well as thromboembolic disease treatment and prevention in high-risk patients. Moreover, nutrition and physical activity interventions are receiving increasing attention as they are crucial to optimize treatment tolerance and efficacy. Of note, they require adaptation to the specificities of PDAC setting and stage of the disease. In this review, we propose an overview of palliative and supportive care interventions in PDAC, with a highlight on nutritional and physical activity management.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30878334     DOI: 10.1016/j.lpm.2019.02.032

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  5 in total

Review 1.  A review of physical activity in pancreatic ductal adenocarcinoma: Epidemiology, intervention, animal models, and clinical trials.

Authors:  Hsiang-Yin Hsueh; Valentina Pita-Grisanti; Kristyn Gumpper-Fedus; Ali Lahooti; Myrriah Chavez-Tomar; Keri Schadler; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2021-10-26       Impact factor: 3.996

2.  Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma.

Authors:  Ilaria Trestini; Luisa Carbognin; Umberto Peretti; Isabella Sperduti; Alberto Caldart; Daniela Tregnago; Alice Avancini; Alessandra Auriemma; Giulia Orsi; Sara Pilotto; Luca Frulloni; Gabriele Capurso; Emilio Bria; Michele Reni; Giampaolo Tortora; Michele Milella
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

Review 3.  Benefitial role of electrochemotherapy in locally advanced pancreatic cancer - radiological perspective.

Authors:  Oliwia Kozak; Stanisław Hać; Joanna Pieńkowska; Michał Studniarek
Journal:  Pol J Radiol       Date:  2022-01-13

4.  Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma.

Authors:  Thomas Kryza; Tashbib Khan; Simon Puttick; Chao Li; Kamil A Sokolowski; Brian Wc Tse; Tahleesa Cuda; Nicholas Lyons; Madeline Gough; Julia Yin; Ashleigh Parkin; Elena I Deryugina; James P Quigley; Ruby H P Law; James C Whisstock; Andrew D Riddell; Andrew P Barbour; David K Wyld; Paul A Thomas; Stephen Rose; Cameron E Snell; Marina Pajic; Yaowu He; John D Hooper
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

5.  Computed Tomographic Sarcopenia in Pancreatic Cancer: Further Utilization to Plan Patient Management.

Authors:  Mustafa Jalal; Jennifer A Campbell; Jonathan Wadsley; Andrew D Hopper
Journal:  J Gastrointest Cancer       Date:  2021-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.